gbs trivalent vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02046148)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Streptococcus sp. group BImmunity, active
Streptococcus sp. group B immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gbs trivalent vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02690181 | Phase 2 | Mar 1, 2016 | GlaxoSmithKline |
| NCT02046148 | Phase 2 | Mar 1, 2014 | GlaxoSmithKline, Novartis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 2 | 1 | 2014 |
| Novartis | For profit | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1